At, My Concierge MD, we know that losing weight is not always easy. That is why we offer semaglutide injections as a way for our patients to lose weight quickly and easily.
If you are interested in losing weight with semaglutide injections, please contact My Concierge MD today. We would be happy to answer any questions you may have about the drug.
The search for a weight loss treatment that is both successful and safe appears to be never-ending. However, semaglutide, the most recent anti-obesity medication, is still making headlines more than a year after it was approved by the US Food and Drug Administration for use in 2021.
The injectable treatment, which was formerly only used to treat diabetes, is the first drug licensed since Saxenda (2014) to treat chronic weight management in the 70% of American adults who are obese or overweight. The efficacy of semaglutide injections for weight loss is being studied further. It also emphasizes the importance of treating obesity as a chronic metabolic disease rather than expecting people to manage their condition exclusively via willpower and lifestyle modifications. However, semaglutide is not a cure-all. It’s also not for everyone.
What is semaglutide injection?
Semaglutide mimics the lower gastrointestinal tract’s glucagon-like peptide 1 hormone. When you eat, your body produces glucagon-like peptide 1 (or GLP-1) to suppress hunger and alert your brain that you’re full. It can help lower blood sugar levels by increasing insulin secretion and decreasing stomach emptying.
These GLP-1 receptors have also been detected in brain regions that govern your appetite and enjoyment of eating. Semaglutide works similarly by decreasing appetite and making you feel fuller for extended periods of time, all while enhancing how your body controls blood sugar levels and stores fat.
Semaglutide was primarily developed for diabetics to help in controlling blood sugar levels and treating diabetic ketoacidosis. Diabetic people can develop diabetic ketoacidosis if their bodies do not produce enough insulin and produce an excess of blood acids known as ketones.
This necessitates immediate medical intervention. Ozempic (semaglutide) is a medication that can be used to treat diabetic ketoacidosis, type 2 diabetes, cardiovascular disease, and weight loss.
What are the benefits of semaglutide injections?
Type 2 diabetes is treated with the drug semaglutide. It belongs to a group of medications known as glucagon-like peptide-1 glp-1 receptor agonists (GLP-1 RAs), which function by promoting the production of insulin from the pancreas while inhibiting the release of glucagon.
Semaglutide injections provide several advantages, including:
Improved blood sugar control:
Studies on the drug’s capacity to decrease blood sugar levels have shown some very positive results. The medication works by encouraging your body to generate more insulin, which aids in controlling the level of blood sugar. Additionally, it aids in reducing the liver’s ability to produce glucose, which also helps to regulate your blood sugar levels. Additionally, it has been shown to lessen cravings and appetite, which may help you eat less overall and lower your blood sugar levels.
Lower risk of cardiovascular disease:
In persons with type 2 diabetes who are at high risk for these disorders, semaglutide has been found to lower the risk of significant cardiovascular events such as heart attack, stroke, and cardiovascular mortality.
Improved cholesterol levels:
Those looking to lower their bad cholesterol levels and raise their good cholesterol levels may find real benefits from the novel and exciting drug semaglutide. It is a once-weekly injectable drug that functions by turning on GLP-1 receptors in the body, which control levels of blood sugar and fat. This indicates that it may aid in lowering your high cholesterol levels and raising your levels of good cholesterol. Additionally, it can aid in lowering high blood pressure, waist circumference, and both body weight and weight at the hips.
Induce weight loss:
It has been demonstrated that the weight loss and maintenance benefits of semaglutide can aid people. According to recent research, those taking the medication dropped an average of 15.3% of their body weight, with some people losing as much as 36.4%. Over the course of the study, the medication was also discovered to be secure and well-tolerated. Participants said they experienced no severe adverse effects from the medication and felt fuller for longer after eating. The study’s findings also demonstrated that Semaglutide was effective in assisting individuals to maintain their weight loss over time.
Those who received semaglutide experienced greater improvements in cardiometabolic risk factors and an increase in participant-reported physical functioning from baseline compared to those on placebo. Gastrointestinal discomfort, such as nausea and diarrhea, was the most frequently encountered side effect; however these were typically short-lived occurrences that abated with time. While fewer participants discontinuing therapy due to gastrointestinal issues (59 [4.5%] vs 5 [0.8%]) were observed among those receiving semaglutide than placebo groups.
Reduced risk of kidney disease:
Recent studies have revealed that this medication can lessen the chance of kidney failure and damage in people with type 2 diabetes. This is excellent news for folks who have the problem since it may assist them in acquiring a disease that could be fatal. According to the study, semaglutide can cut the risk of kidney injury by up to 25%, which is a significant reduction. Additionally, the medication was able to lower the chance of renal failure by up to 15%. This is a positive finding since it suggests that people with type 2 diabetes may be better able to prevent developing this dangerous illness.
Semaglutide may not be appropriate for everyone; thus, using it should be reviewed with a healthcare professional. Semaglutide frequently causes nausea, vomiting, and diarrhea as adverse effects. Pancreatitis and thyroid carcinoma are two uncommon but potentially harmful adverse effects.
In addition to diet and exercise, the U.S. Food and Drug Administration today approved Rybelsus (semaglutide) oral tablets to help adults with type 2 diabetes better regulate their blood sugar levels. The glucagon-like peptide (GLP-1) receptor protein therapy Rybelsus is the first to receive approval for use in the United States and does not require injection. GLP-1 medications are non-insulin therapies for type 2 diabetics.